Indian Journal of Rheumatology

REVIEW ARTICLE
Year
: 2019  |  Volume : 14  |  Issue : 5  |  Page : 76--81

Autoimmune/autoinflammatory syndrome induced by adjuvants: what is it and why the controversy?


Sajal Ajmani 
 Arthritis and Rheumatology Clinic, New Delhi, India

Correspondence Address:
Dr. Sajal Ajmani
Arthritis and Rheumatology Clinic, New Delhi - 110 070
India

Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA) is a group of autoimmune diseases with possible adjuvant-associated causes, such as siliconosis, macrophagic myofasciitis syndrome, Gulf War syndrome, sick building syndrome, and postvaccination autoimmune phenomena. Over time, an international registry with over 500 patients has been established for this conglomeration of rare syndromes. In spite of this, the very existence of ASIA has been debated at times and the diagnostic criteria have come under criticism. The cause-effect relationship between adjuvants and autoimmune phenomenon is difficult to prove due to lack of precisely defined time range between exposure and disease and also due to numerous exposures to adjuvants a person may have in his or her lifetime. The current article attempts at reviewing the clinical features, diagnostic criteria, and evidence for/against the existence of the disease.


How to cite this article:
Ajmani S. Autoimmune/autoinflammatory syndrome induced by adjuvants: what is it and why the controversy?.Indian J Rheumatol 2019;14:76-81


How to cite this URL:
Ajmani S. Autoimmune/autoinflammatory syndrome induced by adjuvants: what is it and why the controversy?. Indian J Rheumatol [serial online] 2019 [cited 2020 Jan 22 ];14:76-81
Available from: http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=5;spage=76;epage=81;aulast=Ajmani;type=0